Product Offerings
Products:
Anthelmintic APIs: Closantel Base, Closantel Sodium BP Vet, Rafoxanide BP Vet, Niclosamide BP Vet, Triclabendazole BP Vet
Sarvani Labs Pvt Ltd is a specialized veterinary Active Pharmaceutical Ingredients (API) manufacturer based in Penuganchiprolu, Andhra Pradesh, India. Established with a vision to deliver high-quality, regulatory-compliant anthelmintic APIs, the company has built a strong presence in domestic and international animal health markets. With a clear focus on livestock parasite control, Sarvani Labs is recognized for its formulation-grade bulk drugs that meet stringent pharmacopeial standards, serving veterinary pharmaceutical manufacturers globally.
Core Business and Offerings
Sarvani Labs operates with a core focus on manufacturing veterinary-grade anthelmintic APIs. These APIs are critical in the formulation of therapeutic solutions aimed at controlling endo- and ectoparasites in cattle, sheep, goats, poultry, and aquaculture. The primary product portfolio includes:
- Closantel Base
- Closantel Sodium BP Vet
- Rafoxanide BP Vet
- Niclosamide BP Vet
- Triclabendazole BP Vet
These APIs are manufactured in compliance with British Pharmacopoeia (BP Vet) standards, ensuring high purity, safety, and batch consistency. The company's customers primarily use these actives in injectable, oral drench, bolus, and premix formulations.
Specialization and Core USP
Sarvani Labs stands out in the Indian veterinary pharmaceutical manufacturing sector due to:
- Narrow product specialization in anthelmintics, allowing deep process optimization and cost competitiveness.
- Compliance with global veterinary pharmacopeia standards (BP Vet), making their products export-ready.
- Multiple points of quality verification, including in-process checks, finished product testing, and third-party certifications.
- Custom manufacturing and contract API production, enabling flexibility for formulation companies and partners seeking consistency in large-scale production.
The company also emphasizes raw material traceability, maintaining transparent documentation for all intermediates and excipients used in synthesis.
Financial Performance
Although privately held and not publicly disclosing financials, Sarvani Labs operates as a medium-sized API manufacturer, with industry estimates suggesting:
- Annual turnover of approximately $3–5 million USD, driven by both Indian market demand and export sales.
- Revenue growth of 15–20% YoY, attributed to expansion in South American, African, and Southeast Asian veterinary markets.
- A consistent portion of earnings reinvested in quality control infrastructure and regulatory documentation development.
The cost-effectiveness of its manufacturing in India allows Sarvani Labs to remain highly competitive in price-sensitive global markets.
Shipment Records
Based on customs and trade intelligence platforms:
- Sarvani Labs exports to over 10 countries, including Egypt, Kenya, Bangladesh, Vietnam, and Mexico.
- Frequent shipment volumes range from 25 kg to 500 kg batches, depending on client formulation scale.
- APIs are shipped under pharmacopeial-grade packaging with certificates of analysis (COAs), MSDS, and regulatory documentation.
Primary export APIs include Closantel Sodium and Triclabendazole, both widely used in large ruminant parasite control.
Target Market
Sarvani Labs primarily caters to:
- Veterinary pharmaceutical manufacturers
- Animal health product formulators
- Global contract development and manufacturing organizations (CDMOs)
- Feed mill integrators producing medicated premixes
Their APIs are commonly used in the treatment and prevention of liver fluke, roundworms, tapeworms, and ectoparasites in production animals.
Capabilities
- cGMP-compliant API manufacturing facility located in Andhra Pradesh
- In-house quality control and analytical laboratories
- Process development and scale-up expertise
- Capability to customize API particle size, moisture content, and polymorph profile
- Regulatory document support, including DMF preparation upon request
Sarvani Labs is equipped to fulfill both standard bulk API requirements and customized production contracts for global formulation partners.
Certifications and Compliance
- APIs conform to British Pharmacopoeia Veterinary (BP Vet) standards
- ISO 9001:2015 certified quality management system
- Regular inspections and audits to maintain GMP standards
- Export licenses and registrations under India’s CDSCO (Central Drugs Standard Control Organization)
- Product documentation includes COA, MSDS, stability data, and regulatory dossiers for client submissions
These certifications position Sarvani Labs as a trusted source of consistent and compliant veterinary APIs.
Customer Testimonials
“Sarvani Labs has been a reliable partner for our closantel-based formulations. Their batch quality and delivery timelines have exceeded expectations.”
– Director, Veterinary Pharma Formulator, Egypt
“Their team offers exceptional technical documentation support, which helped us speed up our regulatory submissions in Latin America.”
– QA/RA Manager, Veterinary Drug Company, Brazil
Major Achievements
- Developed custom synthesis routes for high-purity Rafoxanide with minimal impurity profiles.
- Supported over 30 global customers in registering formulations containing Sarvani APIs.
- Increased production capacity by 25% in 2022 to meet rising demand for veterinary anthelmintics.
- Maintains a repeat customer rate exceeding 90%, indicating high product satisfaction and operational reliability.
- Participated in global B2B pharma platforms and virtual buyer-seller meets organized by Indian government export councils.
Sarvani Labs Pvt Ltd continues to solidify its position as a trusted and compliant supplier of veterinary anthelmintic APIs, enabling global animal health companies to produce safe, effective, and affordable parasitic control solutions for livestock and companion animals.